Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India US Equity Opportunities Fund · Regular ✕HDFC Pharma and Healthcare Fund · Regular ✕

Growth of ₹10,000

Basics

Nippon India US Equity Opportunities FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseNippon IndiaHDFC
NAV₹39.2613₹22.8170
NAV date19 Nov 202620 Nov 2026
History11.3 years3.1 years
Expense ratio2.4%2.1%
Stars★★★★★★★★★★
Growth Score68.3093.90

Returns

Nippon India US Equity Opportunities FundHDFC Pharma and Healthcare Fund
1 month−7.24%+12.87%
3 months−7.77%+6.85%
6 months−1.13%+17.20%
YTD+3.37%+32.43%
1 year+10.36%+30.73%
3 years (CAGR)+14.18%+29.16%
5 years (CAGR)+8.20%—
10 years (CAGR)+14.12%—
Since launch+13.14%+30.28%

Risk

Nippon India US Equity Opportunities FundHDFC Pharma and Healthcare Fund
Volatility13.2%15.8%
Downside volatility8.3%8.6%
Sharpe0.581.44
Sortino0.932.64
Calmar0.751.94
Return / risk1.071.85
Deepest fall−30.89%−15.07%
Days to recover71133
Below its high−9.39%+0.00%

Against benchmark

Nippon India US Equity Opportunities FundHDFC Pharma and Healthcare Fund
Alpha+6.60%+6.36%
Beta0.130.97
R²2.5%85.0%
Up capture41.3%106.7%
Down capture−12.2%74.4%
Tracking error19.2%6.1%
Information ratio0.100.97
Treynor0.540.22

Consistency

Nippon India US Equity Opportunities FundHDFC Pharma and Healthcare Fund
Best 1-year+73.93%+64.96%
Middle 1-year+16.24%+21.84%
Worst 1-year−24.03%+0.52%
1-year periods with a loss11.1%0.0%
Middle 3-year+15.88%+28.68%
Positive months66.7%69.4%
Best day+8.59%+3.19%
Worst day−5.13%−3.62%
Worst 5% day−1.53%−1.50%
Positive days55.4%58.1%
NAVs a year240247

SIP of ₹10,000 a month

Nippon India US Equity Opportunities FundHDFC Pharma and Healthcare Fund
5-year XIRR+12.31%—
5-year value₹8,22,039—
3-year XIRR+9.50%+26.26%
1-year XIRR+0.70%+39.84%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth